PRESS RELEASE: HTL-Strefa Responds to Growing Calls for Affordable Healthcare With Cost-Effective Diabetes Solutions
Amidst recent news on healthcare pricing, HTL-Strefa, part of the MTD Group, reinforces its commitment to delivering innovative, high-quality pen needles at lower costs, with the Droplet brand rapidly expanding across U.S. markets WOODSTOCK, Ga., October 4, 2024 (Newswire.com) – As you may have seen in recent news, there is growing pressure to make healthcare more…
PRESS RELEASE: HTL-Strefa Responds to Growing Calls for Affordable Healthcare With Cost-Effective Diabetes Solutions
Amidst recent news on healthcare pricing, HTL-Strefa, part of the MTD Group, reinforces its commitment to delivering innovative, high-quality pen needles at lower costs, with…
MTD Group (parent company of HTL-Strefa, Inc) completes the acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites
Medical Technology and Devices (MTD; www.mtdglobal.com ) is pleased to announce the successful closing of the acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems (BGM)…
Alternative Solution to Pen Needle Supply Disruption
Dear partner in care of patients with diabetes – We’ve come to learn that there is a significant supply disruption with another leading brand of…
Meet the Thinnest Pen Needle in North America
Designed for comfort, backed by science — Droplet pen needles make insulin delivery smoother and gentler than ever.
